NEIMETH - Neimeth International Pharma
Neimeth International Pharmaceuticals Plc is the resultant company from the management-buy-out of the 60% equity holding of Pfizer Inc. in Pfizer Products Plc. This management-buy-out took place in May 1997 when Pfizer Inc., in pursuit of its global repositioning strategy, divested 60% equity in Pfizer Products Plc. in favour of the existing management. Before the brand name Neimeth International Pharmaceuticals Plc, the company had operated in Nigeria for 40 years, manufacturing, marketing, and distributing Pfizer brands of pharmaceutical and veterinary products in tablets, capsules, ointment/cream, powder, injectables, and oral liquid forms.
Neimeth International Pharma is listed on the Nigerian Stock Exchange (NGX) since September 21st, 1979. Neimeth International Pharma is traded on the NGX under the ticker symbol “NEIMETH”. The International Securities Identification Number (ISIN) of NGX:NEIMETH is NGNEIMETH001. Neimeth International Pharma is currently the 79th most valuable stock on the NGX with a market capitalization of NGN 7.14 billion, which makes about 0.024% of the Nigerian Stock Exchange equity market.
|Last Trading Results|
|Day’s Low Price|
|Day’s High Price|
|Number of Deals||2|
|Growth & Valuation|
|Earnings Per Share|
|Dividend Per Share|
NEIMETH Stock Market Performance
The current share price of Neimeth International Pharma (NEIMETH) is NGN 1.67. NEIMETH closed its last trading day (Monday, June 5, 2023) at 1.67 NGN per share on the Nigerian Stock Exchange (NGX). Neimeth International Pharma began the year with a share price of 1.43 NGN and has since gained 16.8% on that price valuation, ranking it 64th on the NGX in terms of year-to-date performance. Shareholders can be optimistic about NEIMETH knowing the stock has accrued 20% over the past four-week period alone—30th best on NGX.
Neimeth International Pharma is the seventh most traded stock on the Nigerian Stock Exchange over the past three months (Mar 1 - Jun 5, 2023). NEIMETH has traded a total volume of 1.12 billion shares—in 597 deals—valued at NGN 1.65 billion over the period, with an average of 17.7 million traded shares per session. A volume high of 1.07 billion was achieved on March 20th, and a low of 100 on March 10th, for the same period. The table below details the last 10 trading days of activity of Neimeth International Pharma on the Nigerian Stock Exchange.
Profile of Neimeth International Pharmaceuticals Plc
Neimeth International Pharmaceuticals Plc operates in the Health Care sector, specifically, the Pharmaceuticals & Biotechnology industry.
Factsheet of Neimeth International Pharmaceuticals Plc
- Health Care
- Pharmaceuticals & Biotechnology
- Plot 16, Akanni Doherty Layout, Oregun Industrial Estate, Oregun, Lagos, Nigeria
- +234-903-254-3202, +234-815-949-1935
NEIMETH Industrial Market Competitors
Neimeth International Pharmaceuticals Plc, issuers of the NEIMETH stock on the Nigerian Stock Exchange, have six market competitors who are also engaged in the Health Care sector and/or Pharmaceuticals & Biotechnology industry. The table below presents an overview of their market standing.
|GLAXOSMITH||Glaxo Smithkline Consumer||9.03B||7.55||+22.8%|
|MAYBAKER||May & Baker Nigeria||7.33B||4.25||-1.16%|